{"id":33641,"date":"2025-02-07T12:45:23","date_gmt":"2025-02-07T17:45:23","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_scientists&#038;p=33641"},"modified":"2025-07-23T12:48:25","modified_gmt":"2025-07-23T16:48:25","slug":"aldo-ummarino-md-phd","status":"publish","type":"cri_scientists","link":"https:\/\/www.cancerresearch.org\/es\/cri-funded-scientists\/aldo-ummarino-md-phd","title":{"rendered":"Aldo Ummarino, MD, PhD"},"content":{"rendered":"\n<p>Aldo Ummarino, MD, PhD, is an emerging leader in cancer research, developing innovative immunotherapies to combat pancreatic cancer. One of the deadliest and hardest-to-treat cancers, pancreatic cancer has proven resistant to conventional immunotherapy. Dr. Ummarino&#8217;s research focuses on harnessing the power of interferons, immune molecules that can trigger the body\u2019s natural defenses to fight tumors. His preclinical studies have shown promising results, with the potential to eliminate pancreatic tumors in mouse models\u2014a breakthrough that could transform treatment for this aggressive cancer.&nbsp;<\/p>\n\n\n\n<p>Dr. Ummarino\u2019s scientific journey began in Italy, where his early research in gastric lesions and nematode diagnostics laid the foundation for his passion for cancer research. After earning his MD cum laude at the University of Foggia, he moved to Humanitas Research Hospital, one of Italy\u2019s top institutions, to deepen his expertise in cancer-related inflammation. During his PhD, Dr. Ummarino worked under renowned cancer researchers Profs. P. Allavena and A. Mantovani, where he explored the potential of innate immune receptors as cancer therapy targets, producing impactful publications and fostering international collaborations.&nbsp;<\/p>\n\n\n\n<p>His work is grounded in a desire to push scientific boundaries and bring real-world impact to patients. \u201cWe have the potential to revolutionize the treatment landscape for pancreatic cancer,\u201d says Dr. Ummarino. \u201cBy targeting innate immune pathways, we could not only eliminate tumors but also identify new treatment targets for patients who desperately need better options.\u201d&nbsp;<\/p>\n\n\n\n<p>Dr. Ummarino\u2019s research has been supported by prestigious fellowships and collaborations, including a Boehringer Ingelheim Fonds international short-term fellowship at Harvard Medical School. As an early-career researcher, he is poised to make lasting contributions to the field of cancer immunotherapy, with a focus on expanding treatment options and improving patient outcomes worldwide.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Projects and Grants<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">A New Immunotherapy for Pancreatic Cancer Based on Interferon-Induced Immunogenic Cancer Cell Death\u00a0<\/h3>\n\n\n\n<p>Boston Children\u2019s Hospital | Pancreatic Cancer | 2025 | Ivan Zanoni, PhD<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aldo Ummarino, MD, PhD, is an emerging leader in cancer research, developing innovative immunotherapies to combat pancreatic cancer. One of the deadliest and hardest-to-treat cancers, pancreatic cancer has proven resistant to conventional [&hellip;]<\/p>\n","protected":false},"featured_media":33630,"template":"","tax_cancer_type":[351],"tax_grant_type":[486],"tax_award_year":[742],"tax_institutions":[489],"tax_location_states":[490],"class_list":["post-33641","cri_scientists","type-cri_scientists","status-publish","has-post-thumbnail","hentry"],"acf":{"scientist_subhead":"CRI Cinelli Family Foundation Postdoctoral Fellow","quote":"","scientist_last_name":"Ummarino","show_on_landing":true,"scientist_publish_until":"20271231"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aldo Ummarino, MD, PhD - Cancer Research Institute<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aldo Ummarino, MD, PhD - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"Aldo Ummarino, MD, PhD, is an emerging leader in cancer research, developing innovative immunotherapies to combat pancreatic cancer. One of the deadliest and hardest-to-treat cancers, pancreatic cancer has proven resistant to conventional [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-23T16:48:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/aldo-800x800-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd\",\"url\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd\",\"name\":\"Aldo Ummarino, MD, PhD - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/aldo-800x800-1.webp\",\"datePublished\":\"2025-02-07T17:45:23+00:00\",\"dateModified\":\"2025-07-23T16:48:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/aldo-800x800-1.webp\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/aldo-800x800-1.webp\",\"width\":800,\"height\":800,\"caption\":\"Aldo Ummarino, MD, PhD\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aldo Ummarino, MD, PhD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aldo Ummarino, MD, PhD - Cancer Research Institute","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd","og_locale":"es_ES","og_type":"article","og_title":"Aldo Ummarino, MD, PhD - Cancer Research Institute","og_description":"Aldo Ummarino, MD, PhD, is an emerging leader in cancer research, developing innovative immunotherapies to combat pancreatic cancer. One of the deadliest and hardest-to-treat cancers, pancreatic cancer has proven resistant to conventional [&hellip;]","og_url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd","og_site_name":"Cancer Research Institute","article_modified_time":"2025-07-23T16:48:25+00:00","og_image":[{"width":800,"height":800,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/aldo-800x800-1.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd","url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd","name":"Aldo Ummarino, MD, PhD - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/aldo-800x800-1.webp","datePublished":"2025-02-07T17:45:23+00:00","dateModified":"2025-07-23T16:48:25+00:00","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/aldo-800x800-1.webp","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/aldo-800x800-1.webp","width":800,"height":800,"caption":"Aldo Ummarino, MD, PhD"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/aldo-ummarino-md-phd#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Aldo Ummarino, MD, PhD"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"fimg_url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/aldo-800x800-1.webp","_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists\/33641","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_scientists"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/33630"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=33641"}],"wp:term":[{"taxonomy":"tax_cancer_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_cancer_type?post=33641"},{"taxonomy":"tax_grant_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_grant_type?post=33641"},{"taxonomy":"tax_award_year","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_award_year?post=33641"},{"taxonomy":"tax_institutions","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_institutions?post=33641"},{"taxonomy":"tax_location_states","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_location_states?post=33641"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}